Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.